Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Neurotrope, Inc. | v461285_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Neurotrope, Inc. | v461285_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Neurotrope, Inc. | v461285_ex23-1.htm |
| EX-14.1 - EXHIBIT 14.1 - Neurotrope, Inc. | v461285_ex14-1.htm |
| EX-10.34 - EXHIBIT 10.34 - Neurotrope, Inc. | v461285_ex10-34.htm |
| EX-10.33 - EXHIBIT 10.33 - Neurotrope, Inc. | v461285_ex10-33.htm |
| EX-3.1 - EXHIBIT 3.1 - Neurotrope, Inc. | v461285_ex3-1.htm |
| 10-K - FORM 10-K - Neurotrope, Inc. | v461285_10k.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Neurotrope, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2016 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 10, 2017 | /s/ Susanne Wilke, Ph.D. |
| Name: Susanne Wilke, Ph.D. | |
| Title: Chief Executive Officer | |
| Principal Executive Officer | |
| Dated: March 10, 2017 | /s/ Robert Weinstein |
| Name: Robert Weinstein | |
| Title: Chief Financial Officer, Executive Vice President, Treasurer and Secretary | |
| Principal Financial Officer |